Exubera and Subvenite

• Generic Name: insulin inhalation, rapid acting
• Dosage Forms: inhalation powder
• Other Brand Names: Exubera, Afrezza, Exubera, EXUBERA Combination Pack 12, EXUBERA Combination Pack 15, EXUBERA Kit, Afrezza 4 unit- 8 unit, Afrezza 8 unit- 12 unit, Afrezza Titration Pack

Insulin inhalation (Exubera) was withdrawn from the U.S. market in 2007 due to lack of consumer demand for the product. No drug safety concerns were cited in this withdrawal.

Exubera is a rapid-acting form of human insulin that is inhaled through the mouth. It works by lowering levels of glucose (sugar) in the blood.

Exubera is used to treat type 1 (insulin dependent) or type 2 (non-insulin dependent) diabetes in adults.

• Generic Name: lamotrigine
• Dosage Forms: tablet
• Other Brand Names: Lamictal, Lamictal ODT, Lamictal XR, Subvenite, Lamictal, Lamictal ODT, Lamictal XR, Lamictal CD, LaMICtal Starter Kit, LaMICtal ODT Patient Titration Kit, LaMICtal XR Patient Titration Kit, LamoTRIgine Starter Kit, Subvenite Starter Kit

Subvenite is an anti-epileptic medication, also called an anticonvulsant.

Subvenite is used alone or with other medications to treat epileptic seizures in adults and children. This medicine is also used to delay mood episodes in adults with bipolar disorder (manic depression).

Immediate-release Subvenite can be used in children as young as 2 years old when it is given as part of a combination of seizure medications. However, this form should not be used as a single medication in a child or teenager who is younger than 16 years old.

Extended-release Subvenite is for use only in adults and children who are at least 13 years old.

Subvenite may also be used for purposes not listed in this medication guide.